Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dressler

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
European Journal of Neurology|January 3, 2001
Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapyD Dressler
European Neurology|October 13, 2001
Botulinum toxin type B: where do we stand?D Dressler
Der Nervenarzt|July 1, 2006
[Pharmacological aspects of therapeutic botulinum toxin preparations]D Dressler
European Journal of Neurology|November 1, 2011
Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteinsD Dressler
HNO|June 7, 2012
[Pharmacology of botulinum toxin drugs]D Dressler
Der Nervenarzt|December 14, 2004
[Apomorphine in the treatment of Parkinson's Disease]D Dressler
Der Nervenarzt|December 4, 2003
[Antibody-induced failure of botulinum toxin therapy]D Dressler
Journal of Neurology|December 29, 2000
Complete secondary botulinum toxin therapy failure in blepharospasmD Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|March 26, 2008
Botulinum toxin drugs: future developmentsD Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|November 13, 2015
Botulinum toxin drugs: brief history and outlookD Dressler
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
European Journal of Neurology|January 3, 2001
Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapyD Dressler
European Neurology|October 13, 2001
Botulinum toxin type B: where do we stand?D Dressler
Der Nervenarzt|July 1, 2006
[Pharmacological aspects of therapeutic botulinum toxin preparations]D Dressler
European Journal of Neurology|November 1, 2011
Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteinsD Dressler
HNO|June 7, 2012
[Pharmacology of botulinum toxin drugs]D Dressler
Der Nervenarzt|December 14, 2004
[Apomorphine in the treatment of Parkinson's Disease]D Dressler
Der Nervenarzt|December 4, 2003
[Antibody-induced failure of botulinum toxin therapy]D Dressler
Journal of Neurology|December 29, 2000
Complete secondary botulinum toxin therapy failure in blepharospasmD Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|March 26, 2008
Botulinum toxin drugs: future developmentsD Dressler
Journal of Neural Transmission (Vienna, Austria : 1996)|November 13, 2015
Botulinum toxin drugs: brief history and outlookD Dressler
Pageof 20